Enhancement of chemotherapy by manipulation of tumour pH

British Journal of Cancer

Volumn 80, Issue 7, 1999, Pages 1005-1011

  Raghunand, N ^a   He, X ^a   Van Sluis, R ^a   Mahoney, B ^a   Baggett, B ^a   Taylor, C W ^a   Paine Murrieta, G ^a   Roe, D ^a   Bhujwalla, Z M ^b   Gillies, R J ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acid base balance; Bicarbonate; Chemotherapy; Doxorubicin; MRS

Indexed keywords

ANTINEOPLASTIC AGENT; BICARBONATE; DOXORUBICIN; DRINKING WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL STRAIN MCF 7; DRUG CYTOTOXICITY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PH; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; DOXORUBICIN; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; SODIUM BICARBONATE; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0032904346     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690455     Document Type: Article

References (26)

1. Altan N, Chen Y, Schíndler M and Simon SM (1998) Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 187: 1583-1598
2. Bearman SI, Overmoyer BA, Bolwell BJ, Taylor CW, Shpall EJ, Cagnoni PJ, Mechling BE, Ronk B, Baron AE, Purdy MH, Ross M and Jones RB (1997) High dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodes. Bone Marrow Transplant 20: 931-937
3. Cesano A, Visonneau S, Rovera G and Santoli (1997) Synergistic effects of adriamycin and TALL-104 cell therapy against a human gastric carcinoma in vivo. Anticancer Res 17: 1887-1892
4. Corbett TH, Roberts BJ, Trader MW, Laster WR Jr, Griswold DPJ and Schabel FM Jr. (1982) Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. Cancer Treat Rep 66: 1187-1200
5. Durand RE and LePard NE (1997) Tumour blood flow influences combined radiation and doxorubicin treatments. Radiother Oncol 42: 171-179
6. Gillies RJ and Deamer DW (1978) Intracellular pH: methods and applications. Curr Top Bioenergetics 9: 63-87
7. Gillies RI, Didier N and Denton M (1986) Determination of cell number in monolayer cultures. Analyt Biochem 159: 109-113
8. 31P-MRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate. Am J Physiol 195-203
9. Griffiths JR (1991) Are cancer cells acidic? Br J Cancer 64: 425-427
10. Liu C, Lambert JM, Teicher BA, Blattler WA and O'Connor R (1996) Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti B4-blocked ricin and chemotherapeutic drugs. Blood 87: 3892-3898
11. 2+ using the fluorescence of SNARF-1 and Fura-2. Am J Physiol 260: C297-C307
12. McCoy CL, Parkins CS, Chaplin DJ, Griffiths JR, Rodrigues LM and Stubbs M (1995) The effect of blood flow modification on ontra-and extracellular pH measured by 31P magnetic resonance spectroscopy in murine tumours. Br J Cancer 72:
13. Negendank W (1992) Studies of human tumors by MRS: a review. NMR Biomed 5: 303-324
14. Ordidge RJ, Bowley RM and McHale G (1988) A general approach to selection of multiple cubic volume elements using the ISIS technique. Magn Reson Med 8: 323-331
15. Paine-Murrieta GD, Taylor CW, Curtis RA, Lopez MHA, Dorr RT, Johnson CS, Funk CY, Thompson F and Hersh EM (1997) Human tumor models in the severe combined immune deficient (Scid) mouse Cancer Chemother Pharmacol xx: 1-6
16. Passfall J, Pai J, Spies KP, Haller H and Luft FC (1997) Effect of water and bicarbonate loading in patients with chronic renal failure. Clin Nephrol 47: 92-98
17. Polin L, Valeriote F, White K, Panchapor C, Pugh S, Knight J, LoRusso, Hussain M, Liversidge F, Peltier N, Golakoti T, Patterson G, Moore and Corbett TH (1997) Treatment of human prostate tumors PC 3 and TSU-PR1 with standard and investigational agents in SCID mice. Invest New Drugs 15: 99-108
18. Raghunand N, Altbach MI, Van Sluis R, Baggett B, Taylor CW, Bhujwalla ZM and Gillies RJ (1999a) Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P MR spectroscopy. Biopharm Pharmacol 57: 309-312
19. Raghunand N, Martinez-Zaguilan R, Wright SH and Gillies RJ (1999b) pH and drug resistance II: turnover of acidic vesicles and resistance to weakly basic chemotherapeutic drugs. Biochem Pharmacol 57: 1047-1058
20. Roos A (1978) Weak acids, weak bases, and intracellular pH. Respir Physiol 33: 27-30
21. Simon SM and Schindler M (1994) Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 91: 3497-3504
22. Tannock IF and Rotin D (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49: 4373-4384
23. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH, Roe DJ and Trent IM (1991) Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 63: 923-929
24. Verbitsky O, Mizrahi J, Levin M and Isakov E (1997) Effect of ingested sodium bicarbonate on muscle force, fatigue, and recovery. J Appl Physiol 83: 333-337
25. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314
26. Wike-Hooley JL, Haveman J and Reinhold HS (1984) The relevance of tumour pH to the treatment of malignant disease. Radiother Oncol 2: 343-366